Vor Biopharma Inc. (VOR)

♥ 562 Thanks from members

Vor Biopharma Inc. (VOR) displays a mixed market sentiment with a ~$1B market cap, recent positive technical momentum, and a legacy-pivot re-rating, offset by an earnings miss, widening quarterly losses, and cautious analyst stances ahead of 1H 2027 clinical milestones.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →

Other Nasdaq Tickers

NASDAQ

Microchip Technology Incorporated (MCHP)

NASDAQ

Direxion Daily AAPL Bear 1X ETF (AAPD)

NASDAQ

Ascentage Pharma Group International - American Depository Shares (AAPG)

NASDAQ

Direxion Daily AAPL Bull 2X ETF (AAPU)

NASDAQ

Alpha Blue Capital US Small-Mid Cap Dynamic ETF (ABCS)

NASDAQ

AbCellera Biologics Inc. - Common Shares (ABCL)

Entity & Market Metadata

Sector: Health Care Industry: Biotechnology Founder: PureTech Health Founder: Siddhartha Mukherjee Leadership: Robert Forrester (CEO) Holder: PureTech Health Holder: RA Capital Management VOR33 HEAL platform Engineered Stem Cell Therapies #VOR #Vor Biopharma #Biotech stock #NASDAQ VOR #HSC engineering